YC
EXAS

Yarbrough Capital’s Exact Sciences EXAS Stock Holding History

Yarbrough Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,554
Closed -$284K – 166
2025
Q1 		$284K Hold
6,554
– – 0.01% 173
2024
Q4 		$368K Hold
6,554
– – 0.01% 149
2024
Q3 		$446K Hold
6,554
– – 0.02% 143
2024
Q2 		$277K Buy
+6,554
New +$361K 0.01% 177

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Yarbrough Capital's EXAS Position: Q2 2025 in Review

Yarbrough Capital sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 6,554 shares — an estimated $284K sold.

Yarbrough Capital first reported a position in EXAS in Q2 2024 and held it in 4 quarters. The position peaked at $446K in Q3 2024. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Yarbrough Capital reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Yarbrough Capital sold 6,554 Exact Sciences shares in Q2 2025, an estimated $284K.
  • Yarbrough Capital first reported a position in Exact Sciences in Q2 2024 and held it in 4 quarters.
  • Yarbrough Capital's Exact Sciences position peaked at $446K in Q3 2024.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Yarbrough Capital's 13F filing for Q2 2025, filed 15 Jul 2025.